Lipidic Differences of Sperm Between Normal and Low Fertilization Patients
Lipidic Profiles Differences of Sperm Between Normal and Low Fertilization Male Patients in Vitro Fertilization
1 other identifier
interventional
50
1 country
1
Brief Summary
Although in vitro fertilization (IVF) involve the use of semen samples, there is little scientific methodology applied when selecting sperm. To select the most appropriate spermatozoa, first the operator need to define the optimal molecular markers. Sperm lipids may contribute to sperm function, thus the investigator's aim was to compare the lipidic profiles differences of sperm samples used in IVF cycles that ultimately led to normal fertilization or low fertilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 3, 2020
CompletedFirst Submitted
Initial submission to the registry
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
September 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 3, 2020
August 1, 2020
3 months
August 19, 2020
August 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Normal fertilization rate
2PN (two pronuclei and two polar bodies) rate
6 months
Study Arms (2)
Normal fertilization group
EXPERIMENTALSperm samples from the successful fertilization IVF cycles were collected.
Low fertilization group
EXPERIMENTALSperm samples from the low fertilization IVF cycles were collected.
Interventions
The sperm samples were used for lipid extraction. Lipids were analyzed using the UPLC-MS system.
Eligibility Criteria
You may qualify if:
- Tubal factor infertility,
- The women's BMI (Body mass index) ranged from 18.5 to 24,
- The women's AMH (Anti-Müllerian hormone) ranged from 2 to 6.8 ng/ml,
- The oocyte mature rate was greater than 75%,
- ≤ Number of retrieved oocytes ≤ 16.
- Analysis of the spouse's semen conventional parameters showed normal.
You may not qualify if:
- The age is over 35 years old.
- The women with polycystic ovary syndrome (PCOS).
- The endocrine function of the women was disordered.
- The women has metabolic disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tang-Du Hospitallead
Study Sites (1)
Tangdu Hospital
Xi'an, Shaanxi, 710038, China
Study Officials
- STUDY CHAIR
Li Bo, Doctor
Reproductive Medicine Center, Tangdu Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2020
First Posted
September 3, 2020
Study Start
August 3, 2020
Primary Completion
October 31, 2020
Study Completion
December 31, 2020
Last Updated
September 3, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share